Complete Filing Data
Annexon, Inc. reported Stockholders Equity of $211.65 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Annexon, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income Loss | -$206.7M | -$138.2M | -$134.2M | -$141.9M | -$130.3M | -$63.4M | -$37.2M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $2.0K | -$15.0K | $5.0K | $1.0K | -$5.0K | $9.0K | -$14.0K |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$41.0K | $77.0K | $315.0K | -$193.0K | -$98.0K | -$6.0K | |
| Research And Development Expense | $184.7M | $119.4M | $113.8M | $112.5M | $100.1M | $49.3M | $24.5M |
| Operating Income Loss | -$216.4M | -$154.1M | -$143.7M | -$145.6M | -$130.7M | -$63.5M | -$32.5M |
| Operating Expenses | $216.4M | $154.1M | $143.7M | $145.6M | $130.7M | $63.5M | $32.5M |
| General And Administrative Expense | $31.7M | $34.6M | $30.0M | $33.1M | $30.6M | $14.2M | $8.0M |
| Comprehensive Income Net Of Tax | -$206.7M | -$138.1M | -$133.9M | -$142.1M | -$130.4M | -$63.4M | -$37.2M |
| Net Income Loss Available To Common Stockholders Basic | -$208.5M | -$138.2M | -$141.9M | -$130.3M | -$70.3M | -$38.3M | |
| Other Comprehensive Income Loss Net Of Tax | -$39.0K | $62.0K | $320.0K | -$192.0K | |||
| Other Nonoperating Income Expense | $57.0K | $1.0M | |||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$63.4M | -$37.2M | |||||
| Income Tax Expense Benefit | $4.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$54.9M | -$49.2M | -$54.4M | -$34.8M | -$29.6M | -$25.2M | -$32.5M | -$35.2M | -$38.7M | -$35.1M | -$37.1M | -$35.4M | -$35.6M | -$31.3M | -$26.1M | -$15.6M | -$12.2M | -$12.3M | -$10.2M | -$9.4M | -$8.7M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $2.0K | $2.0K | $1.0K | -$12.0K | -$2.0K | -$1.0K | -$5.0K | -$4.0K | -$6.0K | $3.0K | -$3.0K | -$1.0K | -$1.0K | $4.0K | $9.0K | -$11.0K | -$7.0K | -$4.0K | -$6.0K | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $17.0K | -$4.0K | -$101.0K | $164.0K | $12.0K | -$38.0K | $50.0K | $47.0K | $160.0K | $37.0K | -$60.0K | -$196.0K | -$7.0K | $39.0K | -$25.0K | ||||||
| Research And Development Expense | $49.7M | $44.2M | $48.2M | $30.1M | $25.0M | $21.0M | $27.9M | $30.3M | $32.3M | $27.9M | $29.1M | $27.0M | $27.6M | $24.6M | $20.7M | $11.8M | $9.3M | $10.2M | $7.1M | $6.0M | |
| Operating Income Loss | -$57.0M | -$51.7M | -$57.4M | -$39.4M | -$33.6M | -$28.6M | -$34.8M | -$37.7M | -$41.2M | -$36.1M | -$37.4M | -$35.4M | -$35.7M | -$31.4M | -$26.2M | -$15.6M | -$12.2M | -$12.5M | -$9.1M | -$8.2M | |
| Operating Expenses | $57.0M | $51.7M | $57.4M | $39.4M | $33.6M | $28.6M | $34.8M | $37.7M | $41.2M | $36.1M | $37.4M | $35.4M | $35.7M | $31.4M | $26.2M | $15.6M | $12.2M | $12.5M | $9.1M | $8.2M | |
| General And Administrative Expense | $7.3M | $7.6M | $9.2M | $9.3M | $8.6M | $7.6M | $6.9M | $7.4M | $8.9M | $8.2M | $8.3M | $8.4M | $8.1M | $6.8M | $5.5M | $3.8M | $3.0M | $2.2M | $2.0M | $2.2M | |
| Comprehensive Income Net Of Tax | -$54.9M | -$49.2M | -$54.5M | -$34.7M | -$29.6M | -$25.2M | -$32.4M | -$35.1M | -$38.5M | -$35.0M | -$37.2M | -$35.6M | -$35.6M | -$31.3M | -$26.1M | -$15.6M | -$12.2M | -$12.4M | -$10.2M | -$9.4M | |
| Net Income Loss Available To Common Stockholders Basic | -$54.9M | -$51.0M | -$34.8M | -$29.6M | -$35.1M | -$37.1M | -$35.4M | -$35.6M | -$31.3M | -$26.1M | -$22.0M | -$12.5M | -$12.6M | -$10.5M | -$9.7M | ||||||
| Other Comprehensive Income Loss Net Of Tax | $17.0K | -$2.0K | -$101.0K | $166.0K | $13.0K | -$50.0K | $48.0K | $46.0K | $155.0K | ||||||||||||
| Other Nonoperating Income Expense | $82.0K | $79.0K | $142.0K | -$52.0K | $1.0K | $115.0K | $224.0K | $376.0K | |||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$35.6M | -$31.3M | -$15.6M | -$12.2M | -$10.2M | -$9.4M | |||||||||||||||
| Income Tax Expense Benefit | $1.0K | $4.0K | $2.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $211.6M | $293.1M | $250.6M | $231.2M | $231.9M | $344.3M | -$100.5M | -$64.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $163.1M | $50.5M | $226.1M | $141.1M | $76.0M | $268.6M | $43.9M | |
| Cash And Cash Equivalents At Carrying Value | $162.1M | $49.5M | $225.1M | $140.0M | $74.8M | $268.6M | $43.9M | $44.2M |
| Retained Earnings Accumulated Deficit | -$917.4M | -$710.7M | -$572.5M | -$438.3M | -$296.3M | -$166.0M | -$102.6M | |
| Property Plant And Equipment Net | $10.6M | $12.6M | $14.8M | $16.8M | $17.8M | $1.9M | $2.1M | |
| Prepaid Expense And Other Assets Current | $3.8M | $4.4M | $4.1M | $5.4M | $5.0M | $2.8M | $1.5M | |
| Liabilities Current | $42.6M | $30.5M | $17.9M | $22.4M | $21.7M | $10.6M | $4.9M | |
| Liabilities And Stockholders Equity | $277.6M | $350.1M | $297.7M | $285.1M | $287.0M | $355.9M | $49.9M | |
| Liabilities | $65.9M | $57.0M | $47.1M | $53.9M | $55.1M | $11.7M | $6.4M | |
| Common Stock Value | $149.0K | $109.0K | $78.0K | $48.0K | $39.0K | $38.0K | $4.0K | |
| Assets Current | $242.2M | $316.5M | $263.9M | $248.1M | $247.7M | $354.0M | $45.4M | |
| Assets | $277.6M | $350.1M | $297.7M | $285.1M | $287.0M | $355.9M | $49.9M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$29.0K | $10.0K | -$52.0K | -$372.0K | -$180.0K | -$77.0K | -$80.0K | |
| Accounts Payable Current | $14.9M | $10.4M | $5.5M | $7.4M | $11.2M | $3.7M | $2.4M | |
| Available For Sale Securities Debt Securities Current | $76.3M | $262.5M | $34.6M | $102.6M | $167.9M | $82.6M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $112.6M | -$175.6M | $85.1M | $65.0M | -$192.6M | $224.6M | ||
| Accretion Amortization Of Discounts And Premiums Investments | $4.0M | $9.1M | $2.6M | -$73.0K | -$1.3M | -$53.0K | ||
| Restricted Cash Noncurrent | $1.0M | $1.0M | $1.0M | $1.0M | $1.2M | |||
| Operating Lease Right Of Use Asset Amortization Expense | $1.5M | $1.3M | $1.1M | $1.2M | $1.3M | |||
| Operating Lease Right Of Use Asset | $15.2M | $16.7M | $18.0M | $19.1M | $20.3M | |||
| Operating Lease Liability Noncurrent | $23.3M | $26.5M | $29.2M | $31.5M | $33.4M | |||
| Operating Lease Liability Current | $2.9M | $2.5M | $2.2M | $1.3M | $1.2M | |||
| Cash Paid For Amounts Included In The Measurement Of Lease Liability | $5.1M | $4.9M | $4.7M | $10.1M | $996.0K | |||
| Accrued Liabilities Current | $13.4M | $9.3M | $6.5M | $2.2M | ||||
| Other Liabilities Current | $180.0K | $139.0K | ||||||
| Other Assets Noncurrent | $8.5M | $3.2M | $2.4M | |||||
| Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock | $705.0K | $1.1M | ||||||
| Temporary Equity Accretion To Redemption Value Adjustment | $705.0K | $1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $161.4M | $199.0M | $243.8M | $331.6M | $361.1M | $262.4M | $156.8M | $184.7M | $214.9M | $260.6M | $168.0M | $200.6M | $264.5M | $295.3M | $321.4M | $365.5M | -$117.9M | -$112.4M | -$91.8M | -$81.9M | -$72.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $140.5M | $133.3M | $98.2M | $80.6M | $158.3M | $153.0M | $134.2M | $114.6M | $145.2M | $211.7M | $105.6M | $114.0M | $69.7M | $100.8M | $207.8M | $370.7M | $124.8M | $33.3M | ||||
| Cash And Cash Equivalents At Carrying Value | $139.4M | $132.3M | $97.1M | $79.5M | $157.3M | $151.9M | $133.2M | $113.6M | $144.1M | $210.7M | $104.6M | $112.8M | $68.5M | $99.6M | $206.7M | $370.7M | $124.8M | $53.7M | $31.5M | |||
| Retained Earnings Accumulated Deficit | -$869.1M | -$814.2M | -$765.1M | -$662.1M | -$627.3M | -$597.7M | -$544.6M | -$512.1M | -$476.9M | -$403.9M | -$368.8M | -$331.7M | -$258.9M | -$223.3M | -$192.0M | -$142.8M | -$127.2M | |||||
| Property Plant And Equipment Net | $11.2M | $11.7M | $12.2M | $13.2M | $13.7M | $14.2M | $15.3M | $15.8M | $16.3M | $17.1M | $17.4M | $17.8M | $12.2M | $5.1M | $1.4M | $2.0M | $2.0M | |||||
| Prepaid Expense And Other Assets Current | $4.1M | $3.6M | $4.5M | $4.2M | $5.3M | $5.8M | $3.9M | $4.6M | $4.4M | $5.3M | $3.8M | $4.6M | $4.1M | $2.0M | $3.9M | $2.9M | $907.0K | |||||
| Liabilities Current | $43.6M | $40.6M | $33.5M | $20.0M | $17.1M | $13.1M | $17.2M | $17.9M | $22.9M | $20.2M | $20.3M | $17.1M | $11.9M | $10.3M | $10.7M | $9.0M | $12.7M | |||||
| Liabilities And Stockholders Equity | $229.1M | $264.6M | $303.0M | $378.8M | $406.1M | $304.1M | $203.8M | $233.0M | $268.8M | $312.7M | $220.7M | $250.6M | $310.2M | $331.8M | $333.1M | $375.6M | $131.1M | |||||
| Liabilities | $67.7M | $65.6M | $59.2M | $47.2M | $45.0M | $41.7M | $47.0M | $48.3M | $53.9M | $52.1M | $52.7M | $50.0M | $45.7M | $36.4M | $11.6M | $10.1M | $13.9M | |||||
| Common Stock Value | $115.0K | $110.0K | $109.0K | $106.0K | $106.0K | $90.0K | $53.0K | $53.0K | $53.0K | $48.0K | $39.0K | $39.0K | $38.0K | $38.0K | $38.0K | $38.0K | $4.0K | |||||
| Assets Current | $192.8M | $230.6M | $268.2M | $344.3M | $374.0M | $270.7M | $169.2M | $197.6M | $232.5M | $274.8M | $181.4M | $211.3M | $275.5M | $304.4M | $330.5M | $373.6M | $125.7M | |||||
| Assets | $229.1M | $264.6M | $303.0M | $378.8M | $406.1M | $304.1M | $203.8M | $233.0M | $268.8M | $312.7M | $220.7M | $250.6M | $310.2M | $331.8M | $333.1M | $375.6M | $131.1M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$76.0K | -$93.0K | -$91.0K | $77.0K | -$89.0K | -$102.0K | -$123.0K | -$171.0K | -$217.0K | -$406.0K | -$439.0K | -$373.0K | -$75.0K | -$65.0K | -$103.0K | -$78.0K | -$82.0K | |||||
| Accounts Payable Current | $18.2M | $11.5M | $10.4M | $6.7M | $4.1M | $4.0M | $4.8M | $7.2M | $10.3M | $6.9M | $10.3M | $9.4M | $4.8M | $4.2M | $4.5M | $4.0M | $3.1M | |||||
| Available For Sale Securities Debt Securities Current | $49.3M | $94.7M | $166.6M | $260.6M | $211.4M | $113.0M | $32.1M | $79.3M | $84.0M | $58.9M | $73.0M | $93.8M | $202.8M | $202.8M | $120.0M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $47.6M | -$73.2M | $4.1M | $38.0M | -$60.8M | -$10.6M | ||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.9M | $1.1M | $902.0K | -$380.0K | -$180.0K | |||||||||||||||||
| Restricted Cash Noncurrent | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.2M | $1.2M | $1.2M | $1.2M | |||||||
| Operating Lease Right Of Use Asset Amortization Expense | $359.0K | $308.0K | $264.0K | $230.0K | $136.0K | |||||||||||||||||
| Operating Lease Right Of Use Asset | $15.6M | $16.0M | $16.3M | $17.1M | $17.4M | $17.7M | $18.3M | $18.6M | $18.9M | $19.6M | $19.9M | $20.1M | $20.7M | $21.1M | ||||||||
| Operating Lease Liability Noncurrent | $24.1M | $24.9M | $25.7M | $27.2M | $27.9M | $28.5M | $29.8M | $30.4M | $31.0M | $31.9M | $32.4M | $32.9M | $33.8M | $26.2M | ||||||||
| Operating Lease Liability Current | $2.8M | $2.7M | $2.6M | $2.4M | $2.3M | $2.3M | $1.7M | $1.6M | $1.5M | $1.8M | $1.7M | $1.3M | $63.0K | $250.0K | ||||||||
| Cash Paid For Amounts Included In The Measurement Of Lease Liability | $1.3M | $1.2M | $1.2M | $1.1M | $182.0K | |||||||||||||||||
| Accrued Liabilities Current | $10.7M | $6.9M | $10.2M | $10.5M | $9.0M | $10.7M | $11.3M | $8.1M | $6.2M | $7.1M | $5.9M | $5.8M | $4.6M | $9.2M | ||||||||
| Other Liabilities Current | $20.0K | $50.0K | $41.0K | $170.0K | $161.0K | $384.0K | $170.0K | $164.0K | $189.0K | |||||||||||||
| Other Assets Noncurrent | $8.5M | $5.3M | $5.3M | $3.2M | $361.0K | $12.0K | $204.0K | $1.0M | $241.0K | $593.0K | $3.4M | |||||||||||
| Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock | $145.0K | $281.0K | $279.0K | $281.0K | $272.0K | $262.0K | ||||||||||||||||
| Temporary Equity Accretion To Redemption Value Adjustment | $145.0K | $281.0K | $279.0K | $281.0K | $272.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $16.4M | $19.4M | $18.2M | $18.5M | $16.3M | $4.9M | $2.0M |
| Net Cash Provided By Used In Operating Activities | -$186.4M | -$118.0M | -$121.1M | -$116.3M | -$106.1M | -$53.1M | -$28.4M |
| Net Cash Provided By Used In Financing Activities | $108.9M | $161.2M | $135.5M | $122.9M | $1.8M | $360.9M | $28.4M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$598.0K | $300.0K | -$1.4M | $463.0K | $2.6M | $1.3M | -$56.0K |
| Increase Decrease In Accrued Liabilities | $7.2M | $7.3M | -$3.6M | $6.2M | $773.0K | $4.8M | -$20.0K |
| Increase Decrease In Accounts Payable | $4.5M | $4.9M | -$2.1M | -$287.0K | $3.9M | $1.5M | $931.0K |
| Depreciation Depletion And Amortization | $2.2M | $2.2M | $2.1M | $2.1M | $2.1M | $667.0K | $493.0K |
| Net Cash Provided By Used In Investing Activities | $190.1M | -$218.8M | $70.7M | $58.4M | -$88.2M | -$83.2M | -$267.0K |
| Proceeds From Stock Options Exercised | $461.0K | $1.2M | $90.0K | $80.0K | $1.6M | $22.0K | $3.0K |
| Payments To Acquire Property Plant And Equipment | $137.0K | $15.0K | $193.0K | $6.5M | $1.7M | $464.0K | $267.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.0K | -$15.0K | $5.0K | $1.0K | -$5.0K | $9.0K | |
| Payments To Acquire Available For Sale Securities Debt | $212.2M | $583.9M | $108.1M | $113.2M | $225.6M | $82.7M | |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $402.4M | $365.2M | $179.0M | $178.2M | $133.0M | ||
| Increase Decrease In Operating Lease Liabilities | -$2.8M | -$2.4M | -$1.5M | -$1.7M | $1.1M | ||
| Proceeds From Stock Plans | $454.0K | $362.0K | $479.0K | $340.0K | $185.0K | ||
| Increase Decrease In Other Noncurrent Assets | $5.3M | $3.2M | -$96.0K | ||||
| Payments Of Financing Costs | $1.6M | $2.3M | $555.0K | $8.0M | |||
| Increase Decrease In Other Current Liabilities | -$139.0K | $41.0K | $139.0K | ||||
| Proceeds From Issuance Of Common Stock | $28.5M | $44.4M | $18.0M | ||||
| Payments Of Stock Issuance Costs | $3.0M | $1.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $5.1M | $4.7M | $4.6M | $4.3M | $3.0M | $663.0K |
| Net Cash Provided By Used In Operating Activities | -$50.1M | -$28.3M | -$33.0M | -$30.3M | -$23.4M | -$10.0M |
| Net Cash Provided By Used In Financing Activities | $59.0K | $32.4M | $17.6M | $19.0K | $268.0K | -$571.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $22.0K | $1.6M | -$1.1M | -$383.0K | $1.1M | -$314.0K |
| Increase Decrease In Accrued Liabilities | $2.9M | -$3.4M | -$2.8M | -$1.9M | -$718.0K | $523.0K |
| Increase Decrease In Accounts Payable | -$31.0K | -$1.5M | $3.0M | $1.8M | $761.0K | $797.0K |
| Depreciation Depletion And Amortization | $537.0K | $538.0K | $536.0K | $518.0K | $538.0K | $131.0K |
| Net Cash Provided By Used In Investing Activities | $97.6M | -$77.3M | $19.5M | $68.3M | -$37.6M | |
| Proceeds From Stock Options Exercised | $62.0K | $198.0K | $111.0K | $19.0K | $268.0K | |
| Payments To Acquire Property Plant And Equipment | $74.0K | $137.0K | $5.2M | $32.0K | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$12.0K | -$5.0K | $3.0K | -$1.0K | -$11.0K | |
| Payments To Acquire Available For Sale Securities Debt | $61.8M | $100.3M | $31.4M | $5.9M | $42.5M | |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $159.5M | $23.0M | $51.1M | $79.4M | $5.0M | |
| Increase Decrease In Operating Lease Liabilities | -$664.0K | -$570.0K | -$348.0K | -$412.0K | -$176.0K | |
| Proceeds From Stock Plans | ||||||
| Increase Decrease In Other Noncurrent Assets | $2.0M | $361.0K | $12.0K | $241.0K | ||
| Payments Of Financing Costs | $3.0K | $917.0K | $525.0K | |||
| Increase Decrease In Other Current Liabilities | $9.0K | $204.0K | $50.0K | |||
| Proceeds From Issuance Of Common Stock | $33.1M | $18.0M | ||||
| Payments Of Stock Issuance Costs | $75.0K | $571.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.34 | -$1.01 | -$1.77 | -$2.60 | -$3.40 | -$4.15 | -$88.30 |
| Weighted Average Number Of Shares Outstanding Basic | 155.1M | 137.4M | 75.7M | 54.7M | 38.3M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 155.1M | 137.4M | 75.7M | 54.7M | 38.3M | ||
| Earnings Per Share Basic | $-1.34 | $-1.01 | $-1.77 | $-2.60 | $-3.40 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 38.3M | 17.0M | 433.5K | ||||
| Common Stock Shares Outstanding | 149.4M | 109.4M | 78.4M | 47.7M | 38.6M | 38.2M | 433.7K |
| Common Stock Shares Issued | 149.4M | 109.4M | 78.4M | 47.7M | 38.6M | 38.2M | 433.7K |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 150.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.37 | -$0.34 | -$0.37 | -$0.25 | -$0.23 | -$0.21 | -$0.43 | -$0.47 | -$0.52 | -$0.51 | -$0.96 | -$0.92 | -$0.93 | -$0.82 | -$0.68 | -$0.77 | -$28.87 | -$29.10 | -$24.14 | -$22.30 |
| Weighted Average Number Of Shares Outstanding Basic | 149.1M | 148.3M | 148.1M | 139.9M | 130.1M | 122.7M | 75.3M | 75.2M | 73.9M | 68.7M | 38.6M | 38.6M | 38.3M | 38.3M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 149.1M | 148.3M | 148.1M | 139.9M | 130.1M | 122.7M | 75.3M | 75.2M | 73.9M | 68.7M | 38.6M | 38.6M | 38.3M | 38.3M | ||||||
| Earnings Per Share Basic | $-0.37 | $-0.34 | $-0.37 | $-0.25 | $-0.23 | $-0.21 | $-0.43 | $-0.47 | $-0.52 | $-0.51 | $-0.96 | $-0.92 | $-0.93 | $-0.82 | ||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 38.6M | 38.3M | 38.3M | 38.2M | 28.5M | 433.7K | 433.7K | 433.7K | 433.7K | |||||||||||
| Common Stock Shares Outstanding | 38.2M | 433.7K | ||||||||||||||||||
| Common Stock Shares Issued | 38.2M | 433.7K | ||||||||||||||||||
| Common Stock Shares Authorized | 300.0M | 239.1M | ||||||||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $16.4M | $19.4M | $18.2M | $18.5M | $16.3M | $4.9M | $2.0M |
| Stock Issued During Period Value Stock Options Exercised | $461.0K | $1.2M | $145.0K | $80.0K | $1.6M | $22.0K | $3.0K |
| Interest And Other Non Operating Income Expense | $9.7M | $15.9M | $9.5M | $3.7M | $390.0K | $57.0K | |
| Additional Paid In Capital | $1.13B | $1.00B | $823.0M | $669.8M | $528.4M | $510.3M | $2.2M |
| Stock Issued During Period Value Employee Stock Purchase Plan | $454.0K | $362.0K | $479.0K | $340.0K | $185.0K | ||
| Stock Issued During Period Shares Stock Options Exercised | 195.6K | 382.1K | 76.9K | 15.4K | 391.3K | 9.5K | |
| Capital Expenditures Incurred But Not Yet Paid | $110.0K | $5.5M | $19.0K | ||||
| Stock Issued During Period Value New Issues | $27.4M | $42.8M | $262.4M | ||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $1.1M | $1.5M | $8.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.8M | $4.2M | $5.1M | $4.6M | $4.9M | $4.7M | $4.5M | $4.7M | $4.6M | $4.9M | $4.5M | $4.3M | $4.4M | $4.5M | $3.0M | $1.5M | $763.0K | $663.0K | $610.0K | $437.0K | $466.0K |
| Stock Issued During Period Value Stock Options Exercised | $3.0K | $62.0K | $530.0K | $171.0K | $217.0K | $111.0K | $45.0K | $19.0K | $322.0K | $534.0K | $268.0K | $22.0K | $3.0K | ||||||||
| Interest And Other Non Operating Income Expense | $2.1M | $2.6M | $3.0M | $4.6M | $4.0M | $3.4M | $2.3M | $2.5M | $2.6M | $1.0M | $272.0K | $53.0K | $82.0K | $79.0K | $142.0K | ||||||
| Additional Paid In Capital | $1.03B | $1.01B | $1.01B | $993.5M | $988.3M | $860.1M | $701.5M | $697.0M | $692.0M | $664.8M | $537.3M | $532.6M | $523.5M | $518.7M | $513.5M | $508.3M | $9.4M | ||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $182.0K | $215.0K | $345.0K | $113.0K | $118.0K | ||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 43.1K | 105.5K | 55.6K | 2.7K | 74.9K | 0.00 | 0.00 | ||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $15.0K | $5.0K | $801.0K | ||||||||||||||||||
| Stock Issued During Period Value New Issues | $13.5M | $6.1M | $32.2M | $17.5M | $122.6M | $262.4M | |||||||||||||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $697.0K | $480.0K | $933.0K | $525.0K | $9.5M |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.